|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Physiology and Biophysics, University of Calgary, Calgary, Canada
2 Physiology and Biophysics, University of Calgary, Calgary, Canada; Pharmacology & Therapeutics, Univ of Calgary, 3330 Hospital Dr NW, Calgary, T2N 4N1, Canada
* To whom correspondence should be addressed. E-mail: zamponi{at}ucalgary.ca.
Direct interactions between the presynaptic N type calcium channel and the
subunit of the heterotrimeric G protein complex cause voltage dependent inhibition of N type channel activity, crucially influencing neurotransmitter release and contributing to analgesia caused by opioid drugs. Previous work using chimeras of the G protein
subtypes G
1 and G
5 identified two 20-amino acid stretches of structurally contiguous residues on the G
1 subunit as critical for inhibition of the N type channel (Doering et al., J. Biol. Chem. 279, 29709-29717). To identify key modulation determinants within these two structural regions, we performed scanning mutagenesis in which individual residues of the G
1 subunit were replaced by corresponding G
5 residues. Our results show that G
1 residue Ser189 is critical for N type calcium channel modulation, whereas none of the other G
1 mutations caused statistically significant effects on the ability of G
1 to inhibit N type channels. Structural modeling shows residue 189 is surface exposed, consistent with the idea that it may form a direct contact with the N type calcium channel
1 subunit during binding interactions.
This article has been cited by other articles:
![]() |
S. D. DePuy, J. Yao, C. Hu, W. McIntire, I. Bidaud, P. Lory, F. Rastinejad, C. Gonzalez, J. C. Garrison, and P. Q. Barrett The molecular basis for T-type Ca2+ channel inhibition by G protein beta2{gamma}2 subunits PNAS, September 26, 2006; 103(39): 14590 - 14595. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |